BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 29107091)

  • 1. The hypothalamus as the primary brain region of metabolic abnormalities in APP/PS1 transgenic mouse model of Alzheimer's disease.
    Zheng H; Zhou Q; Du Y; Li C; Xu P; Lin L; Xiao J; Gao H
    Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):263-273. PubMed ID: 29107091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using
    Li XY; Men WW; Zhu H; Lei JF; Zuo FX; Wang ZJ; Zhu ZH; Bao XJ; Wang RZ
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27763550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomere length and micronuclei trajectories in APP/PS1 mouse model of Alzheimer's disease: Correlating with cognitive impairment and brain amyloidosis in a sexually dimorphic manner.
    Guo X; Li J; Qi Y; Chen J; Jiang M; Zhu L; Liu Z; Wang H; Wang G; Wang X
    Aging Cell; 2024 May; 23(5):e14121. PubMed ID: 38450924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-Specific Metabolomics Analysis Identifies the Liver as a Major Organ of Metabolic Disorders in Amyloid Precursor Protein/Presenilin 1 Mice of Alzheimer's Disease.
    Zheng H; Cai A; Shu Q; Niu Y; Xu P; Li C; Lin L; Gao H
    J Proteome Res; 2019 Mar; 18(3):1218-1227. PubMed ID: 30592618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional metabolic alteration of Alzheimer's disease in mouse brain expressing mutant human APP-PS1 by 1H HR-MAS.
    Woo DC; Lee SH; Lee DW; Kim SY; Kim GY; Rhim HS; Choi CB; Kim HY; Lee CU; Choe BY
    Behav Brain Res; 2010 Jul; 211(1):125-31. PubMed ID: 20307581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Region-specific metabolic alterations in the brain of the APP/PS1 transgenic mice of Alzheimer's disease.
    González-Domínguez R; García-Barrera T; Vitorica J; Gómez-Ariza JL
    Biochim Biophys Acta; 2014 Dec; 1842(12 Pt A):2395-402. PubMed ID: 25281826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose tolerance and insulin sensitivity are impaired in APP/PS1 transgenic mice prior to amyloid plaque pathogenesis and cognitive decline.
    Macklin L; Griffith CM; Cai Y; Rose GM; Yan XX; Patrylo PR
    Exp Gerontol; 2017 Feb; 88():9-18. PubMed ID: 28025127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the APP/PS1 mouse model of Alzheimer's disease in senescence accelerated background.
    Lok K; Zhao H; Shen H; Wang Z; Gao X; Zhao W; Yin M
    Neurosci Lett; 2013 Dec; 557 Pt B():84-9. PubMed ID: 24176881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic fate of glucose in the brain of APP/PS1 transgenic mice at 10 months of age: a
    Zhou Q; Zheng H; Chen J; Li C; Du Y; Xia H; Gao H
    Metab Brain Dis; 2018 Oct; 33(5):1661-1668. PubMed ID: 29946959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitrosylation of Vesicular Transporters in Brain of Amyloid Precursor Protein/Presenilin 1 Double Transgenic Mice.
    Wang Y; Zhou Z; Tan H; Zhu S; Wang Y; Sun Y; Li XM; Wang JF
    J Alzheimers Dis; 2017; 55(4):1683-1692. PubMed ID: 27911305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Ames dwarf mutation attenuates Alzheimer's disease phenotype of APP/PS1 mice.
    Puig KL; Kulas JA; Franklin W; Rakoczy SG; Taglialatela G; Brown-Borg HM; Combs CK
    Neurobiol Aging; 2016 Apr; 40():22-40. PubMed ID: 26973101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late-life environmental enrichment preserves short-term memory and may attenuate microglia in male APP/PS1 mice.
    Stuart KE; King AE; King NE; Collins JM; Vickers JC; Ziebell JM
    Neuroscience; 2019 Jun; 408():282-292. PubMed ID: 30999032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of serum β-amyloid peptides, α2-macroglobulin, complement factor H, and clusterin levels in APP/PS1 transgenic mice during progression of Alzheimer's disease.
    Wang D; Di X; Fu L; Li Y; Han X; Wu H; Cai L; Meng X; Jiang C; Kong W; Su W
    Neuroreport; 2016 Oct; 27(15):1114-9. PubMed ID: 27541273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.
    Lok K; Zhao H; Zhang C; He N; Shen H; Wang Z; Zhao W; Yin M
    J Neurol Sci; 2013 Dec; 335(1-2):145-54. PubMed ID: 24095271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CC chemokine receptor 2 deficiency aggravates cognitive impairments and amyloid pathology in a transgenic mouse model of Alzheimer's disease.
    Naert G; Rivest S
    J Neurosci; 2011 Apr; 31(16):6208-20. PubMed ID: 21508244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reproduction,genotype identification and evaluation of APP/PS1 transgenic mice].
    Tan L; Li HQ; Li YB; Liu W; Pang W; Jiang YG
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Feb; 34(2):111-114. PubMed ID: 29926672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-asarone improves learning and memory and reduces Acetyl Cholinesterase and Beta-amyloid 42 levels in APP/PS1 transgenic mice by regulating Beclin-1-dependent autophagy.
    Deng M; Huang L; Ning B; Wang N; Zhang Q; Zhu C; Fang Y
    Brain Res; 2016 Dec; 1652():188-194. PubMed ID: 27737765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reverting Metabolic Dysfunction in Cortex and Cerebellum of APP/PS1 Mice, a Model for Alzheimer's Disease by Pioglitazone, a Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Agonist.
    Chang KL; Wong LR; Pee HN; Yang S; Ho PC
    Mol Neurobiol; 2019 Nov; 56(11):7267-7283. PubMed ID: 31016475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease.
    Hansen HH; Fabricius K; Barkholt P; Kongsbak-Wismann P; Schlumberger C; Jelsing J; Terwel D; Termont A; Pyke C; Knudsen LB; Vrang N
    PLoS One; 2016; 11(7):e0158205. PubMed ID: 27421117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.